期刊文献+

转移性睾丸非精原细胞瘤化疗后腹膜后淋巴结清扫术的疗效及预后因素分析 被引量:2

Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis
原文传递
导出
摘要 目的 探讨转移性睾丸非精原细胞瘤化疗后腹膜后淋巴结清扫术(PC-RPLND)的疗效及淋巴结病理为坏死的相关预后因素.方法 回顾性分析2001年3月至2014年12月于中山大学肿瘤防治中心泌尿外科接受PC-RPLND治疗的43例转移性睾丸非精原细胞瘤患者资料,年龄12~58岁,平均(29.0±11.5)岁.临床分期Ⅱ期22例,Ⅲ期21例.睾丸原发灶病理类型:含精原细胞瘤成分19例,胚胎癌成分22例,卵黄囊瘤成分13例,绒癌成分3例,成熟畸胎瘤成分11例,未成熟畸胎瘤成分2例.所有患者在睾丸肿瘤切除术后均先行化疗,再行腹膜后淋巴结清扫(RPLND).RPLND术后定期复查血常规、生化常规、胸部、腹部和盆腔CT或超声检查.采用t检验、x2检验和Fisher精确概率法分析患者临床资料与化疗后淋巴结坏死的相关性,并采用logistic回归分析进行多因素分析.结果 PC-RPLND手术时间50~715 min,平均278 min;出血量50~5 000ml,平均425 ml,8例需输血,2例手术需其他科协助.PC-RPLND术后并发症情况:肠梗阻4例,乳糜性腹水4例,术后高热1例,逆行射精10例.腹膜后淋巴结直径0.8~18.2 cm,平均3.8 cm.PC-RPLND术后腹膜后淋巴结病理类型:组织坏死15例,畸胎瘤17例;活性癌细胞11例.术后随访6~ 169个月,中位随访时间46个月,39例患者无肿瘤复发或转移,7例患者肿瘤复发,其中5例死亡.多因素分析结果显示,肿瘤收缩率(HR=0.016,95% CI:0~0.698,P=0.032)和化疗前乳酸脱氢酶(LDH)水平(HR=25.811,95%CI:0.678~982.624,P=0.017)为化疗后腹膜后淋巴结坏死的预后因素.结论 腹膜后淋巴结清扫术是睾丸非精原细胞瘤化疗后残余病灶的有效治疗方式.化疗前血清LDH正常和化疗后肿瘤缩小明显(≥50%)的病例,腹膜后残存淋巴结为坏死组织的可能性相对更高,可以作为避免行PC-RPLND的参考因素. Objective To explore the clinical outcome of advanced testicular nonseminomatous germ cell cancer patients undergoing post chemotherapy retroperitoneal lymph node dissection (PC-RPLND),and to analyze the relevant prognostic factors of lymph node pathological.Methods A total of 43 consecutive testicular nonseminomatous germ cell cancer patients underwent PC-RPLND between March 2001 and December 2014 in Department of Urology at Sun Yat-sen University Cancer Center were retrospectively reviewed.The average age of the patients was (29.0± 11.5) years (ranging from 12 to 58 years).Before PC-RPLND,22 patients were classified as phase Ⅱ,while 21 were phase Ⅲ.Primary tumor histology revealed seminomatous elements in 19 cases,embryonal cell carcinoma in 22 cases,yolk sac tumor in 13 cases,chorionic carcinoma in 3 cases,mature teratomatous elements in 11 and immature teratomatous elements in 2 cases.Patients were treated with cisplatin-based chemotherapy after orchectomy and then underwent surgical resection of retroperitoneal lymph nodes.After PC-RPLND,all patients underwent a periodic review including the blood routine,biochemistry routine and computed tomography or ultrasonograph of the chest,the abdomen and the pelvis.The association of pathological data with patient's clinic features and the correlations between molecular features detected with each other were assessed by the t test,x2 and Fisher's exact test.Multivariate logistic regression were used to assess prognostic factors.Results The median operative time was 278 minutes (ranging from 50 to 715 minutes).Median blood loss was 425 ml (ranging from 50 to 5 000 ml).Eight patients received blood transfusion intra-operatively,2 patients underwent adjunctive surgical procedures,4 patients developed ileus and 4 had an ascites chylosus following PC-RPLND,1 patient had a postoperative hyperthermia and retrograde ejaculation was present in 10 patients.The transverse diameter of the residual tumor in patients ranged from 0.8 to 18.2 cm.Necrosis
出处 《中华外科杂志》 CAS CSCD 北大核心 2017年第8期603-607,共5页 Chinese Journal of Surgery
关键词 睾丸肿瘤 化学疗法 非精原细胞瘤 腹膜后淋巴结清扫 Testicular neoplasms Chemotherapy Non-seminomatous germ cell tumors Post chemotherapy retroperitoneal lymph node dissection
  • 相关文献

参考文献2

二级参考文献31

  • 1刘卓炜,丘少鹏,周芳坚,梅骅,秦自科,韩辉.保留神经腹膜后淋巴结清除术治疗睾丸肿瘤[J].中华泌尿外科杂志,2005,26(7):491-493. 被引量:7
  • 2Donohue J P, Foster R S. Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques[J]. Urol Clin North Am, 1998,25(3): 461-468. 被引量:1
  • 3International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers [J]. J Clin Oncol, 1997; 15(2) :594-603. 被引量:1
  • 4Huddart R A, Birtle A J. Recent advances in the treatment of testicular cancer[ J ]. Expert Rev Anticancer Ther, 2005,5 ( 1 ) : 123-138. 被引量:1
  • 5Hilton S, Herr H W, Teitcher J B, et al. CT detection of retroperitoneal lymph node metastases in patients with clinical stage Ⅰ testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. [J]. AJR Am J Roentgenol, 1997,169(2) : 521-525. 被引量:1
  • 6Cremerius U, Wildberger J E, Borchers H, et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testieular cancer?-Results of a study in 50 patients[J]. Urology, 1999,54(5):900-904. 被引量:1
  • 7Nicolai N, Mieeli R, Artusi R, et al. A simple model for predicting nodal metastasis in patients with clinical stage Ⅰ nonseminomatous germ cell testicular tumors undergoing retropefitoneal lymph node dissection only[J]. J Urol, 2004, 171(1): 172-176 被引量:1
  • 8Heidenreich A, Albers P, Hartmann M, et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group [J]. J Urol, 2003,169(5) : 1710-1714. 被引量:1
  • 9Mykletun A, Dahl A A, Haaland C F, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer[J]. J Clin Oncol, 2005,23 (13) : 3061-3068. 被引量:1
  • 10Travis L B, Fossa S D, Schonfeld S J, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors[J]. J Natl Cancer Inst, 2005,97(18) : 1354-1365. 被引量:1

共引文献9

同被引文献4

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部